BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1283171)

  • 1. Keratin expression in normal skin and epidermal neoplasms demonstrated by a panel of monoclonal antibodies.
    Perkins W; Campbell I; Leigh IM; MacKie RM
    J Cutan Pathol; 1992 Dec; 19(6):476-82. PubMed ID: 1283171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of keratin 16 in normal and lesional skin of solitary and multiple Bowen's disease using monoclonal antibody Ks 8.12 staining].
    Sheu HM; Ko SS; Yu HS
    J Formos Med Assoc; 1991 Dec; 90(12):1252-5. PubMed ID: 1724782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-cadherin expression in skin tumors using an AMeX immunohistostaining method.
    Koseki S; Ansai S; Aoki T; Hozumi Y; Mitsuhashi Y; Kondo S
    J Dermatol; 2000 May; 27(5):307-11. PubMed ID: 10875196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-8 immunoreactivity in malignant tumours of the skin.
    Bornscheuer E; Schröder JM; Christophers E; Sticherling M
    Acta Derm Venereol; 1996 May; 76(3):210-3. PubMed ID: 8800301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma.
    Jang TJ
    Yonsei Med J; 2002 Jun; 43(3):304-8. PubMed ID: 12089736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies specific for subsets of epidermal keratins: biochemical and immunocytochemical characterization--applications in pathology and cell culture.
    Knight J; Gusterson B; Jones RR; Landells W; Wilson P
    J Pathol; 1985 Apr; 145(4):341-54. PubMed ID: 2582105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bcl-6 protein in normal skin and epidermal neoplasms.
    Kanazawa N; Moriyama M; Onizuka T; Sugawara K; Mori S
    Pathol Int; 1997 Sep; 47(9):600-7. PubMed ID: 9311010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
    Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
    Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of basal cell keratin 14 expression in Bowen's disease: a possible marker for tumour progression.
    Komine M; Okinaga M; Takeda F; Nashiro K; Kikuchi K; Murakami T; Soma Y; Tamaki K
    Br J Dermatol; 2001 Aug; 145(2):223-8. PubMed ID: 11531783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of L-type amino acid transporter 1 in various skin lesions.
    Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
    Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of cell proliferation in benign, premalignant and malignant skin lesions.
    Bordbar A; Dias D; Cabral A; Beck S; Boon ME
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):229-35. PubMed ID: 17525640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratins in primary cutaneous amyloidosis.
    Huilgol SC; Ramnarain N; Carrington P; Leigh IM; Black MM
    Australas J Dermatol; 1998 May; 39(2):81-5. PubMed ID: 9611375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
    Fukumaru K; Yoshii N; Kanzaki T; Kanekura T
    J Dermatol; 2007 Nov; 34(11):746-53. PubMed ID: 17973813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin 10 and Ki-67 nuclear marker expression in keratoacanthoma and squamous cell carcinoma.
    Basta-Juzbasić A; Klenkar S; Jakić-Razumović J; Pasić A; Loncarić D
    Acta Dermatovenerol Croat; 2004; 12(4):251-6. PubMed ID: 15588557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical staining patterns of alpha-keratins in normal tissues from two reptile species: implications for characterization of squamous cell carcinomas.
    Orós J; López-Yánez M; Rodríguez F; Calabuig P; Castro PL
    BMC Vet Res; 2018 Jul; 14(1):219. PubMed ID: 29980226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of lamins depends on epidermal differentiation and transformation.
    Oguchi M; Sagara J; Matsumoto K; Saida T; Taniguchi S
    Br J Dermatol; 2002 Nov; 147(5):853-8. PubMed ID: 12410693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of simple epithelial keratins 8 and 18 in epidermal neoplasia.
    Markey AC; Lane EB; Churchill LJ; MacDonald DM; Leigh IM
    J Invest Dermatol; 1991 Nov; 97(5):763-70. PubMed ID: 1717607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma.
    Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Chen SJ; Tomoeda H; Uenotsuchi T; Tu YT; Furue M; Urabe K
    J Dermatol Sci; 2008 Sep; 51(3):210-5. PubMed ID: 18547788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.